OncoProteomics Laboratory, Department of Medical Oncology, VUmc-Cancer Center Amsterdam, VU University Medical Center, The Netherlands.
Proteomics Clin Appl. 2010 Jul;4(6-7):613-7. doi: 10.1002/prca.200900179. Epub 2010 Mar 29.
For biomarker discovery in cerebrospinal fluid (CSF), removal of major serum proteins is advantageous as more CSF proteins including brain-derived proteins can be identified. Our goal was to create a reproducible discovery workflow with acceptable throughput that can identify 500-1000 CSF proteins in small volumes of CSF.
In this study, we compared the performance of two multi-affinity depletion methods in spin filter format: MARS Human 14 and Seppro-IgY-14. To this end, we analyzed depleted and bound CSF fractions isolated from 0.5 mL aliquots of the same CSF sample (n=3 per depletion method) by label-free GeLC-MS/MS-based proteomics and normalized spectral counting.
The whole CSF dataset contained 884 proteins identified at high confidence. Depletion spin filter performance was assessed in terms of sensitivity and reproducibility of the CSF analysis. MARS and IgY-14 spin filters yielded comparable reproducibility of protein identification (71-74%) and quantification (CV 17-18%) but a significant difference in the total number of identified CSF proteins (767 and 703 proteins, respectively).
The MARS filter compared to IgY-14 filter provides a CSF analysis with enhanced proteome coverage. We anticipate that this enhanced sensitivity will facilitate biomarker discovery in early stages of cancer or neurological disease.
为了在脑脊液(CSF)中发现生物标志物,去除主要的血清蛋白是有利的,因为可以鉴定出更多包括脑源性蛋白在内的 CSF 蛋白。我们的目标是创建一个具有可接受通量的可重复发现工作流程,该流程可以在小体积的 CSF 中鉴定出 500-1000 种 CSF 蛋白。
在这项研究中,我们比较了两种多亲和性耗尽方法在自旋过滤格式中的性能:MARS Human 14 和 Seppro-IgY-14。为此,我们通过无标记 GeLC-MS/MS 基于蛋白质组学和标准化谱计数分析了从相同 CSF 样本的 0.5 mL 等分试样中分离出的耗尽和结合 CSF 级分(每种耗尽方法各 3 个样本)。
整个 CSF 数据集包含 884 种高置信度鉴定的蛋白质。根据 CSF 分析的灵敏度和重现性来评估整个 CSF 数据集的耗尽自旋过滤性能。MARS 和 IgY-14 自旋过滤器在蛋白质鉴定的重现性(71-74%)和定量(CV 17-18%)方面表现相当,但鉴定的 CSF 蛋白总数存在显著差异(分别为 767 和 703 种蛋白)。
与 IgY-14 过滤器相比,MARS 过滤器提供了增强的 CSF 分析的蛋白质组覆盖范围。我们预计,这种增强的灵敏度将有助于在癌症或神经疾病的早期阶段发现生物标志物。